Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cancer. 2014 Mar 26;120(13):1985–1992. doi: 10.1002/cncr.28688

Table 4.

Isolation of Organisms from Blood Cultures, according to Prophylactic Antibiotic Regimen

Antibiotic Regimen All A B C P value, A vs. B
No. evaluable courses 426 113 274 39
No. of courses with bacteremia 81 55* 22 4 <0.0001
No. of identified bacteria 94 59 31 4 <0.0001
Gram-positive bacteria (n)
  Viridans group streptococci 37 33 (7) 3 (2) 1 (1) 0.001
  Enterococcus species 8 1 7 0
  Bacillus cereus 4 2 (1) 2 0
  Coagulase-negative Staphylococcus 4 0 1 3
  Stomatococcus mucilaginosus 4 3 1 0
  Streptococcus pneumoniae 1 1 0 0
  Abiotrophia defectiva 1 0 1 0
  Lactobacillus rhamnosus/casei 1 0 1 0
  Rothia dentocariosa 1 0 1 0
  Granulicatella adiacens 1 0 1 0
Total gram-positive (n) 62 40 18 4 0.0003
Gram-negative bacteria (n)
  Escherichia coli 11 7 4 0
  Pseudomonas aeruginosa 7 3 4 0
  Enterobacter cloacae 6 4 2 0
  Klebsiella pneumoniae 3 2 1 0
  Neisseria subflava/sicca 1 0 1 0
  Moraxella nonliquefaciens 1 1 0 0
  Burkholderia cepacia 1 1 0 0
  Capnocytophaga sputigena 1 0 1 0
  Sphingomonas species 1 1 0 0
Total gram-negative (n) 32 19 13 0 0.001
*

One patient had 2 episodes of bacteremia in a course.

Bloodstream infection was defined by Centers for Disease Control and Prevention (CDC) criteria, with the following exception for common commensals: even one positive blood culture was considered to indicate a bloodstream infection with viridans streptococci or Bacillus cereus in patients with grade 3 or 4 neutropenia. These episodes are shown in the parentheses.

A: Either patients received no prophylactic antibiotics or they received only prophylactic oral cephalosporins.

B: Prophylaxis with IV cefepime only or IV vancomycin plus an oral cephalosporin, oral ciprofloxacin, or IV cefepime.

C: Not evaluable.